⌘K

Login Start Free

Home/Filings/4/0001179110-15-012119

4//SEC Filing

MOMENTA PHARMACEUTICALS INC 4

Accession 0001179110-15-012119

CIK 0001235010operating

View on SEC.gov Company Profile

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 12:43 PM ET

Size

7.8 KB

Accession

0001179110-15-012119

Insider Transaction Report

Form 4

Period: 2015-08-10

MOMENTA PHARMACEUTICALS INCMNTA

Franken Michael

President, Biosimilars Busines

Transactions

Sale
Common Stock
2015-08-10$22.36/sh−20,000$447,200→ 39,001 total
Exercise/Conversion
Stock Option (Right to Buy)
2015-08-10+20,000→ 50,000 total
Exercise: $17.23From: 2014-12-10Exp: 2023-12-10→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock
2015-08-10$17.23/sh+20,000$344,600→ 59,001 total

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

MOMENTA PHARMACEUTICALS INC

CIK 0001235010

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001235010

Filing Metadata

Form type: 4
Filed: Aug 13, 8:00 PM ET
Accepted: Aug 14, 12:43 PM ET
Size: 7.8 KB

View on SEC.gov